SCHEMBL17029109

SCHEMBL17029109

Cc1ccc(C(=O)NCCCc2ccncc2)s1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.76
▸ RAB9A P51151 5/20 0.76
▸ SMN1; SMN2 Q16637 3/20 0.76
▸ USP2 O75604 1/20 0.76
▸ L3MBTL1 Q9Y468 1/20 0.76
▸ ALDH1A1 P00352 1/20 0.60
▸ NAMPT P43490 3/20 0.59
▸ POLB P06746 2/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ AKT3 Q9Y243 1/20 0.47
▸ ACKR3 P25106 1/20 0.47
▸ GAA P10253 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.46
▸ HDAC2 Q92769 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12789016 0.92 RAB9A (0.71) NPC1RAB9ASMN1; SMN2USP2L3MBTL1
SCHEMBL14625417 0.86 NPC1 (0.56) NPC1RAB9ASMN1; SMN2USP2L3MBTL1
SCHEMBL1588059 0.85 NPC1 (0.54) NPC1RAB9ASMN1; SMN2USP2L3MBTL1
SCHEMBL12529773 0.84 RAB9A (0.54) NPC1RAB9ASMN1; SMN2USP2L3MBTL1
SCHEMBL1588442 0.84 NPC1 (0.54) NPC1RAB9ASMN1; SMN2USP2L3MBTL1
SCHEMBL12529399 0.83 NPC1 (0.53) NPC1RAB9ASMN1; SMN2USP2L3MBTL1
SCHEMBL12722682 0.83 POLB (0.56) NPC1RAB9ASMN1; SMN2USP2L3MBTL1
SCHEMBL8966475 0.81 NAMPT (0.56) NPC1RAB9ASMN1; SMN2USP2L3MBTL1
SCHEMBL12124465 0.78 RAB9A (0.67) NPC1RAB9ASMN1; SMN2USP2L3MBTL1
SCHEMBL12124269 0.77 NPC1 (0.65) NPC1RAB9ASMN1; SMN2USP2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9115341-B2 Method for expanding hematopoietic stem cells using heterocyclic compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2015-08-25 — — US disclosed
Send feedback